EUVIMEDOpdag EUVIMED
Systematische ÜbersichtMetaanalyseOpen access · CC BY 4.0

Efficacy and Effectiveness of the Recombinant Zoster Vaccine Against Herpes Zoster, Herpes Zoster Ophthalmicus, Postherpetic Neuralgia and Dementia: A Systematic Review and Meta‐Analysis

E Heen iD, J Øverbø iD, I H Tveteraas, S L Solberg, H Nøkleby, J E Midtbø iD, F Di Rusco, F Kasteng iD, A Ersson, S Andersson, K Johansen, L K Juvet iD

Reviews in Medical Virology · 2026

DOI: 10.1002/rmv.70203 ↗

At a glance

Systematische Übersicht in Reviews in Medical Virology, 2026. Written by E Heen and 11 co-authors. Institution: Norwegian Institute of Public Health, Oslo, Norway. Major MEDLINE topics: Neuralgia, Postherpetic, Herpes Zoster Vaccine, Herpes Zoster, Dementia. 89 references. The full text is freely available (open access, CC BY 4.0). Funded by: Norwegian Institute of Public Health, Public Health Agency of Sweden.

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

Herpes zoster (HZ, shingles) constitutes a significant public health concern, particularly in ageing populations, and there is growing global interest in the recombinant zoster vaccine (RZV) from a public health perspective. In this systematic review with meta‐analysis, we assessed the efficacy and effectiveness of RZV against HZ and its complications, including a possible association with a reduced risk of dementia, among immunocompetent individuals aged 50 years and older. We synthesised the latest evidence on long‐term effects, incorporating recent data from both trials and real‐world effectiveness studies. A total of 27 publications based on 18 primary studies, 3 randomised controlled trials (RCTs) and 15 observational studies, were included. RZV provides very high protection against HZ in immunocompetent adults ≥ 50 years in RCTs, with approximately 95% efficacy and high certainty of evidence (CoE) according to GRADE. Observational studies also consistently indicate substantial protection, but effect estimates vary across settings (high CoE). Among vaccinated individuals who develop HZ, RZV is associated with reduced loss of quality of life and decreased analgesic use. The vaccine also substantially reduces the risk of herpes zoster ophthalmicus (HZO) (high CoE) and likely postherpetic neuralgia (PHN) (moderate CoE). Long‐term follow‐up suggests durable protection for at least 11 years (low CoE). RZV may be associated with a reduced risk of dementia (low CoE), due to uncertainty the true effect may be substantially different, and similar associations have been observed with other vaccines and may be confounded by healthy vaccinee bias.

Subjects

MeSH terms (MEDLINE)

Neuralgia, PostherpeticHerpes Zoster VaccineHerpes ZosterDementiaHerpes Zoster OphthalmicusVaccine EfficacyHumansVaccines, SyntheticTreatment OutcomeRandomized Controlled Trials as TopicMiddle AgedHerpesvirus 3, Human

Substances

Herpes Zoster VaccineVaccines, Synthetic

Authors and institutions

  • Norwegian Institute of Public Health, Oslo, Norway.
  • Public Health Agency of Sweden, Solna, Sweden.
  • Department of Communicable Disease Control and Prevention, Region Jämtland Härjedalen, Östersund, Sweden.
  • Department of Global Public Health, Karolinska Institute, Stockholm, Sweden.

ORCID profiles: E Heen, J Øverbø, J E Midtbø, F Kasteng, L K Juvet

Funding

  • Norwegian Institute of Public Health
  • Public Health Agency of Sweden

Cite

APA

Heen, E., Øverbø, J., Tveteraas, I. H., Solberg, S. L., Nøkleby, H., Midtbø, J. E., Di Rusco, F., Kasteng, F., Ersson, A., Andersson, S., Johansen, K., & Juvet, L. K. (2026). Efficacy and Effectiveness of the Recombinant Zoster Vaccine Against Herpes Zoster, Herpes Zoster Ophthalmicus, Postherpetic Neuralgia and Dementia: A Systematic Review and Meta‐Analysis. Reviews in Medical Virology. https://doi.org/10.1002/rmv.70203

Vancouver

Heen E, Øverbø J, Tveteraas IH, Solberg SL, Nøkleby H, Midtbø JE, et al. Efficacy and Effectiveness of the Recombinant Zoster Vaccine Against Herpes Zoster, Herpes Zoster Ophthalmicus, Postherpetic Neuralgia and Dementia: A Systematic Review and Meta‐Analysis. Reviews in Medical Virology. 2026. doi:10.1002/rmv.70203

BibTeX
@article{Heen2026,
  author = {Heen, E and Øverbø, J and Tveteraas, I H and Solberg, S L and Nøkleby, H and Midtbø, J E and Di Rusco, F and Kasteng, F and Ersson, A and Andersson, S and Johansen, K and Juvet, L K},
  title = {Efficacy and Effectiveness of the Recombinant Zoster Vaccine Against Herpes Zoster, Herpes Zoster Ophthalmicus, Postherpetic Neuralgia and Dementia: A Systematic Review and Meta‐Analysis},
  journal = {Reviews in Medical Virology},
  year = {2026},
  doi = {10.1002/rmv.70203}
}
Start for free →